Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ARKK vs GSK✓SelectedUSD · GSKARKK vs GSK performance historyLatest closeAs of+0.31%11/18
Stock and ETF performance explorer

ARKK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+58.3%
GSK return
+56.0%
Excess return
+2.3%
Maximum drawdown
-39.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.3%+1.7%+0.4%
7D-9.4%-3.1%-6.3%-9.3%
30D-13.7%-0.9%-12.8%-13.6%
3M-10.2%-4.2%-6.1%-10.0%
6M-4.6%-1.6%-3.0%-4.6%
YTD-7.6%+2.6%-10.2%-7.8%
1Y-5.2%+6.2%-11.4%-5.6%
All+58.3%+56.0%+2.3%+44.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling